{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:57:09Z","timestamp":1793973429687,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/modpathol.2016.111","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T08:47:32Z","timestamp":1466153252000},"page":"1038-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization"],"prefix":"10.1016","volume":"29","author":[{"given":"Hyungjin","family":"Rhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hae","family":"Nahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haeryoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Ju","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.111_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1038\/modpathol.2016.111_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2016.111_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2016.111_bib4","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2016.111_bib5","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","article-title":"The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype","volume":"8","author":"Heddleston","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1038\/modpathol.2016.111_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1038\/modpathol.2016.111_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/hep.26345","article-title":"Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course","volume":"58","author":"Muramatsu","year":"2013","journal-title":"Hepatology"},{"key":"10.1038\/modpathol.2016.111_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2016.111_bib9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/hep.24559","article-title":"Human hepatocellular carcinomas with \u201cStemness\u201d-related marker expression: keratin 19 expression and a poor prognosis","volume":"54","author":"Kim","year":"2011","journal-title":"Hepatology"},{"key":"10.1038\/modpathol.2016.111_bib10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/hep.25570","article-title":"A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition","volume":"55","author":"Seok","year":"2012","journal-title":"Hepatology"},{"key":"10.1038\/modpathol.2016.111_bib11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1038\/modpathol.2016.111_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1038\/modpathol.2016.111_bib13","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2016.111_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1478-3231.2009.02166.x","article-title":"Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma","volume":"30","author":"Chua","year":"2010","journal-title":"Liver Int"},{"key":"10.1038\/modpathol.2016.111_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2012.09.026","article-title":"Marginal survival benefit in the treatment of early hepatocellular carcinoma","volume":"58","author":"Midorikawa","year":"2013","journal-title":"J Hepatol"},{"key":"10.1038\/modpathol.2016.111_bib16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1245\/s10434-007-9685-0","article-title":"Early hepatocellular carcinoma: pathology, imaging, and therapy","volume":"15","author":"Takayama","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/modpathol.2016.111_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"key":"10.1038\/modpathol.2016.111_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2013.04.006","article-title":"How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?","volume":"59","author":"Otto","year":"2013","journal-title":"J Hepatol"},{"key":"10.1038\/modpathol.2016.111_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MCG.0b013e31822b36f6","article-title":"Beyond the Milan criteria: what risks for patients with hepatocellular carcinoma progression before liver transplantation?","volume":"46","author":"De Carlis","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1038\/modpathol.2016.111_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jhep.2011.03.007","article-title":"EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization","volume":"55","author":"Gillmore","year":"2011","journal-title":"J Hepatol"},{"key":"10.1038\/modpathol.2016.111_bib21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jhep.2015.01.022","article-title":"Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma","volume":"62","author":"Kim","year":"2015","journal-title":"J Hepatol"},{"key":"10.1038\/modpathol.2016.111_bib22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ijrobp.2004.11.031","article-title":"Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells","volume":"61","author":"Vordermark","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/modpathol.2016.111_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-94-007-7359-2_13","article-title":"Carbonic Anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells","volume":"75","author":"McDonald","year":"2014","journal-title":"Subcell Biochem"},{"key":"10.1038\/modpathol.2016.111_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.humpath.2012.06.004","article-title":"Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity","volume":"44","author":"Currie","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2016.111_bib25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/modpathol.2016.111_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/lt.20128","article-title":"Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis","volume":"10","author":"Roayaie","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1038\/modpathol.2016.111_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archsurg.2007.39","article-title":"Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators","volume":"143","author":"Zimmerman","year":"2008","journal-title":"Arch Surg"},{"key":"10.1038\/modpathol.2016.111_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2015.07.025","article-title":"Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation","volume":"63","author":"Miltiadous","year":"2015","journal-title":"J Hepatol"},{"key":"10.1038\/modpathol.2016.111_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0033-1345721","article-title":"Molecular mechanisms of HBV-associated hepatocarcinogenesis","volume":"33","author":"Guerrieri","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1038\/modpathol.2016.111_bib30","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1038\/sj.onc.1211000","article-title":"Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells","volume":"27","author":"Yoo","year":"2008","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2016.111_bib31","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-10-3951","article-title":"Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?","volume":"71","author":"Arzumanyan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.111_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/onc.2015.122","article-title":"Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2","volume":"35","author":"Fan","year":"2016","journal-title":"Oncogene"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:50:20Z","timestamp":1760230220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0893395222015551"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.111","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}